- Evaluation of clinical trial eligibility and prognostic indices in a population‐based cohort of systemic peripheral T‐cell lymphomas from the Danish Lymphoma Registry
Martin Bjerregaard Pedersen et al, 2015, Hematological Oncology CrossRef - Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma
Daisuke Kurita et al, 2015, International Journal of Hematology CrossRef - Pirarubicin‐based intensive chemotherapy followed by consolidative high‐dose chemotherapies for peripheral T‐cell lymphomas: A noncomparative phase 2 study
Hiromichi Takahashi et al, 2022, Hematological Oncology CrossRef - Role of upfront autologous transplant for peripheral T-cell lymphoma patients achieving a complete remission with first-line therapy: a systematic review and meta-analysis
L. Girard et al, 2024, Bone Marrow Transplantation CrossRef - Topotecan combined with Ifosfamide, Etoposide, and l-asparaginase (TIEL) regimen improves outcomes in aggressive T-cell lymphoma
YaJuan Shao et al, 2015, Medical Oncology CrossRef - Hematopoietic Stem Cell Transplantation in Lymphomas: including our hospital experience
Hiromichi Takahashi et al, 2015, Journal of Nihon University Medical Association CrossRef